Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss from cancer treatment is very distressing for women due to its impact on self-image and social stigma.

People undergoing chemotherapy need better support and information to cope with hair loss.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

The new visual scale is a quick and effective way to measure hair loss in women.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Treating hair loss requires a comprehensive approach that addresses both physical and emotional aspects, with a focus on diagnosis, patient education, and good communication.

Australian women with female pattern hair loss have a poorer quality of life, and starting treatment doesn't immediately improve it.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Targeting psychosocial factors can help reduce self-stigma in people with chronic skin diseases.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Environmental factors like temperature and nutrition affect hair growth, with humans showing seasonal hair growth differences.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

Lupus patients' body image issues significantly affect their mental health and need more support.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Most women in the study lost hair due to stress, fever, childbirth, surgery, or thyroid issues, with low hemoglobin levels also common.

Severe hair loss in women increases the risk of mental health issues, especially social anxiety.

Stress can trigger or worsen alopecia areata.

Hair transplantation is a viable treatment for some types of female hair loss, with careful donor assessment and attention to psychological factors.

Children's hair loss has many causes and requires careful diagnosis and personalized treatment, including emotional support.

Preventing hair loss is more effective than regrowth; oral finasteride is a realistic option.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Young men with mild hair loss who experience significant social and emotional distress are more likely to have sexual problems.

Alopecia areata in Taif is common, mainly immune-related, and best treated with topical corticosteroids and vitamins.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Future anxiety about male pattern baldness is linked to personality traits and social perceptions.